Platform
Modules
By sector
By sector
By standard
Blog
News
Events
AMedP-1.12
Suppliers producing or packaging medical and dental materiel for NATO defence contracts, and the national medical services that exchange and mark it in theatre
AMedP-1.12 sets NATO's procedures for exchanging non-expendable medical and dental equipment and labelling pharmaceutical supplies between nations, given force through STANAG 2128 and naming no certification scheme.
AMedP-1.12 is the NATO Allied Medical Publication that standardises how nations exchange medical and dental property and how they mark medical and pharmaceutical supplies, so that "cross-servicing amongst the Medical Services of the NATO Forces" is possible. In practice that means two things: non-expendable equipment that travels with a patient between nations' care - a stretcher, a ventilator - has to be tracked and returned to whichever nation supplied it, and pharmaceutical or medical supplies have to carry information another nation's medical staff can read and rely on. This page covers what the publication is for, who it addresses, and how it reaches an organisation; it does not reproduce the marking codes or item lists that sit in the document's own clauses.
STANAG 2128 is the NATO agreement that gives AMedP-1.12 its force: the agreement of nations to use this publication is recorded in that STANAG, and AMedP-1.12 is the procedure document the STANAG points to. Ratification is a national act, and for a nation that has ratified it, the publication is "effective upon receipt". For an organisation supplying medical or dental materiel into a NATO nation's stock, the practical trigger is a national specification or a defence contract that names AMedP-1.12 or STANAG 2128, not the publication's existence in NATO's catalogue.
A patient moving through a multinational medical evacuation chain carries equipment that belongs to whichever nation first treated them, and a pharmaceutical supply issued by one nation's medical services may end up read and used by another's. AMedP-1.12 exists so that both of those handoffs work: a common rule for returning non-expendable equipment to its nation of origin, and a common minimum for what a pharmaceutical or medical supply's label has to say, so that storage limits, contents and expiry are legible regardless of which nation packed it. The document also sets a common colour-marking convention for self-injection devices, so that a device's contents can be recognised across nations without relying on a shared language on the label.
AMedP-1.12 addresses the Medical Services of the NATO Forces, and specifically, in its own words, "each nation providing support of medical material or pharmaceuticals to other nations", who carry the marking and return responsibilities the document sets out. It does not address a supplier or manufacturer directly. In practice, its labelling and marking requirements reach whoever produces or packages medical and dental materiel for a nation's stock once a national specification or contract calls the standard up. Beyond ratification and being "effective upon receipt" for the adopting nation, it says nothing about timing within a procurement programme.
AMedP-1.12 is short, organised around one substantive chapter of four clauses.
Exchange procedures (clause 2.1). When a patient transfers between nations, the receiving nation returns non-expendable medical and dental equipment to the nation that supplied it, at the point of transfer where that is possible, or replaces it with equivalent materiel where it is not. Equipment that has to accompany the patient further is returned as soon as possible afterwards, and in the meantime has to be marked in plain text with the supplying nation's identity. Nations arrange property exchange points, staffed by personnel familiar with each other's equipment, at whatever level the operation requires.
Labelling pharmaceutical and medical supplies (clause 2.2). Medical materiel carrying a storage or transport condition has to be marked with that condition. Pharmaceuticals need the generic name and the quantity of contents in metric units on the label, any storage or transport condition beyond the ordinary, and a date of expiry as a minimum, with a production date and lot number expected where possible.
Responsibility of the providing nation (clause 2.3). A nation supplying medical materiel or pharmaceuticals to another nation is responsible for the required storage and transport conditions having held all the way to the point of transfer, not only at the point of dispatch.
Self-injection devices (clause 2.4). The document sets a common colour-marking convention so that a device's contents can be recognised regardless of which nation issued it, with a fluorescent-marking recommendation for low-light conditions, and leaves room for a nation to add further markings under its own legislation on toxic substances.
AMedP-1.12 names no certification body, no accreditation scheme and no periodic assessment cycle. What the document does describe is national ratification of STANAG 2128; it is silent on how compliance with its own exchange and marking procedures is checked once a nation has ratified. Where an organisation is asked to evidence that its labelling or marking meets clauses 2.1 or 2.2, that happens through whatever national acceptance or contract process invoked the standard, not through any scheme NATO administers or recognises.
AMedP-1.12 is an operational standard, not a management-system one: the work it demands - marking equipment with its nation of origin, labelling pharmaceutical packaging with contents and expiry, staffing a property exchange point - happens on the ground and in production, not in software. Where an organisation sits inside that chain, typically as a supplier producing or packaging medical or dental materiel for a NATO nation's stock under a defence contract, ComplyTrain is the place the underlying process gets documented and evidenced: the labelling procedure that meets clause 2.2, the marking work instruction for non-expendable items under clause 2.1, and the training record showing staff know both.
What ComplyTrain does not do: it does not mark a physical item, label a physical pharmaceutical package, or run a property exchange point. Those remain physical, on-the-ground tasks; ComplyTrain documents and evidences that the task was carried out to the procedure, it does not carry the task out itself. What actually applies to a given contract is set by the customer's quality clause, not by this page; the standards explorer shows what else sits alongside AMedP-1.12 and STANAG 2128, and we are glad to talk through what a specific tasking or contract is asking for.
Tell us how you need to work with AMedP-1.12 and what you need from it. We will come back to you about what ComplyTrain can do.
Thank you. Your list is on its way to your inbox, and we will come back to you on what working with these standards in ComplyTrain involves, usually within one business day.
It binds through STANAG 2128, the NATO agreement recording nations' commitment to use it. Whether it is mandatory for a given supplier depends on the national specification or contract that invokes it, not on the publication's existence in NATO's catalogue.
No. The document names no certification body or accreditation scheme. Meeting its labelling and marking requirements is a matter for whatever national acceptance or contract process called the standard up, not for an accredited body issuing a certificate.
Edition A, Version 2, promulgated 16 June 2021. It supersedes Edition A, Version 1, which nations are instructed to destroy in accordance with their local procedure for document destruction.
STANAG 2128 is the agreement by which nations commit to use AMedP-1.12; AMedP-1.12 is the procedure document itself, covering the exchange, marking and labelling requirements. A nation ratifies the STANAG, not the AMedP directly.
One system for the whole compliance programme. Start with the module you need most.
Collect information the same way every time, and decide in advance what happens next.
Know whether your controls are operating, not just whether a policy says they exist.
Turn the compliance work you already know about into a plan with owners, dependencies and dates.
Know what you can offer, and hold the evidence behind every configuration you offer it in.
Eight built-in reports across every module, scheduled, delivered, and filed where the evidence lives.
The sector news that matters to your organisation - read and rated by AI, and delivered as a scheduled digest in your own language.
AI reads the tender pack and pulls out the requirements, deadlines and rules - then helps you draft the response from your own approved content, with you reviewing every step.
One current register of the suppliers and partners you depend on - each risk-assessed, re-assessing itself on schedule, and wired straight into your risk register.
See every requirement you face - across every standard, plus your own contracts and policies - traced to the documents, evidence and processes that satisfy it.
Identify, score, treat and review your risks in one place - with AI to help anyone run a proper assessment, and a defensible trail behind every decision.
Assign training, prove it was understood, and hold the competence records an auditor asks for.
Draft compliance documents with AI, keep every version under control, and export them beautifully branded - all in one place.
Audits, corrective actions, processes and approvals in one quality system, organised around ISO 9001.
Medical device manufacturers operate under more regulatory pressure than almost any other sector outside pharmaceuticals. The rules govern how you design a device, how you make it, how you track it after it ships, and how you respond when something goes wrong.
Learn how EU dual-use export controls apply to encryption, sensors, and software, how classification works under Annex I, and why sending source code by email can count as an export.
A practical way to turn in-your-head risk management into a register that survives staff turnover and answers the risk questions now showing up in tenders.